Jingli Zhang Selected Research

Jingli Zhang Research Topics

Disease

35	Neoplasms (Cancer) 01/2024 - 05/2005
21	Mesothelioma 01/2023 - 05/2005
9	Malignant Mesothelioma 01/2019 - 02/2009
5	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 05/2005
4	Inflammation (Inflammations) 05/2024 - 02/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 05/2005
3	Lung Neoplasms (Lung Cancer) 01/2018 - 09/2011
2	Neuroblastoma 02/2024 - 03/2008
2	Colorectal Neoplasms (Colorectal Cancer) 03/2021 - 12/2007
2	Adenocarcinoma of Lung 01/2020 - 06/2012
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 12/2018
1	Phlebitis 05/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2024
1	Vascular Malformations 05/2024
1	Thrombophlebitis 05/2024
1	Varicose Ulcer (Ulcer, Venous) 05/2024
1	Ulcer 05/2024
1	Cholangiocarcinoma 01/2024
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2022
1	Pre-Eclampsia (Preeclampsia) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 02/2020
1	Ventilator-Associated Pneumonia 02/2020
1	Diarrhea 02/2020
1	Sepsis (Septicemia) 02/2020
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Cerebral Hemorrhage 01/2019
1	Cerebral Infarction 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Diabetes Mellitus 01/2019
1	Headache (Headaches) 02/2018
1	Epilepsy (Aura) 02/2018
1	Dizziness (Lightheadedness) 02/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Hypercalcemia (Milk Alkali Syndrome) 01/2018
1	Hyperphosphatemia 01/2018
1	Mason-Type Diabetes 01/2018
1	Disease Progression 01/2018

Drug/Important Bio-Agent (IBA)

19	MesothelinIBA 01/2022 - 05/2005
12	Immunotoxins (Immunotoxin)IBA 01/2020 - 12/2007
10	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2012
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2005
4	AntigensIBA 05/2016 - 09/2011
3	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020 - 01/2006
3	Monoclonal AntibodiesIBA 11/2012 - 02/2009
2	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 01/2020
2	LMB-100IBA 01/2020 - 03/2017
2	MethyltransferasesIBA 01/2020 - 12/2017
2	Insulin (Novolin)FDA Link 01/2018 - 11/2012
2	CyclinsIBA 01/2018 - 01/2014
2	LigandsIBA 11/2016 - 02/2014
2	ExotoxinsIBA 11/2014 - 05/2010
2	AntioxidantsIBA 02/2014 - 02/2012
2	FlavonoidsIBA 02/2014 - 03/2008
2	Differentiation AntigensIBA 12/2012 - 05/2005
2	Immunoconjugates (Immunoconjugate)IBA 09/2011 - 01/2011
2	AntibodiesIBA 01/2011 - 05/2005
1	Therapeutic UsesIBA 05/2024
1	Pregnane X ReceptorIBA 05/2024
1	Cystatin CIBA 01/2024
1	CreatinineIBA 01/2024
1	Indicators and Reagents (Reagents)IBA 01/2024
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Antinuclear AntibodiesIBA 02/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	EpitopesIBA 01/2022
1	LipopolysaccharidesIBA 12/2021
1	HMGB1 Protein (HMG1)IBA 12/2021
1	anagliptinIBA 12/2021
1	Fluorouracil (Carac)FDA LinkGeneric 03/2021
1	Fibronectins (Fibronectin)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	olaparibIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	NivolumabIBA 01/2020
1	Blocking AntibodiesIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Deubiquitinating EnzymesIBA 01/2020
1	Poly Adenosine Diphosphate RiboseIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	talazoparibIBA 01/2020
1	pembrolizumabIBA 01/2020
1	B7-H1 AntigenIBA 01/2020
1	PlatinumIBA 01/2019
1	Peptides (Polypeptides)IBA 12/2018
1	lanthanum carbonate (Fosrenol)FDA Link 01/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	Phosphorus (Red Phosphorus)IBA 01/2018

Therapy/Procedure

13	Therapeutics 01/2023 - 05/2005
5	Drug Therapy (Chemotherapy) 03/2021 - 12/2007
2	Catheters 02/2020 - 01/2019
1	Ultrasonic Therapy 05/2024
1	Intravenous Administration 01/2022
1	Mechanical Ventilators (Ventilator) 01/2019
1	Urinary Catheters 01/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2018
1	Immunotherapy 01/2018
1	Renal Dialysis (Hemodialysis) 01/2018